ES2053702T3 - Nuevas formulas de galenica de accion programada. - Google Patents
Nuevas formulas de galenica de accion programada.Info
- Publication number
- ES2053702T3 ES2053702T3 ES88121777T ES88121777T ES2053702T3 ES 2053702 T3 ES2053702 T3 ES 2053702T3 ES 88121777 T ES88121777 T ES 88121777T ES 88121777 T ES88121777 T ES 88121777T ES 2053702 T3 ES2053702 T3 ES 2053702T3
- Authority
- ES
- Spain
- Prior art keywords
- new
- active ingredient
- galenica
- therapeutic
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940079593 drug Drugs 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 230000001225 therapeutic effect Effects 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- -1 BRONQUIUM DILATOR Substances 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 229940124549 vasodilator Drugs 0.000 abstract 1
- 239000003071 vasodilator agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Abstract
NUEVAS FORMULAS GALENICAS CON LIBERACION PROGRAMADA, A SER ADMINISTRADO POR VIA ORAL, CONTENIENDO COMO INGREDIENTE ACTIVO UNA DROGA SELECCIONADA DE DROGAS NO ESTEROIDES ANTIINFLAMATORIA, BRONQUIO DILATADOR, VASODILATADOR, CARDIOVASCULAR Y RELAJANTE DE MUSCULO. EN ESTAS NUEVAS FORMULAS, UNA PARTE DEL INGREDIENTE ACTIVO ES LIBERADO EN UN CORTO TIEMPO, TAL QUE LA DROGA PUEDE RAPIDAMENTE DESARROLLAR SU ACCION TERAPEUTICA QUE ALCANZA LOS NECESARIOS NIVELES HEMATICOS, MIENTRAS LA PARTE REMANENTE DEL CONSTITUYENTE ACTIVO ES LIBERADO EN UN INTERVALO MAS LARGO DE TIEMPO PARA PERMITIR LA COBERTURA TERAPEUTICA HASTA LA SUBSECUENTE ADMINISTRACION. DICHA COBERTURA TERAPEUTICA PUEDE IGUALAR LAS ULTIMAS 24 HORAS; ASI LAS NUEVAS FORMULAS GALENICAS OBJETO DEL PRESENTE INVENTO SON CONVENIENTES PARA UNA VEZ AL DIA LA ADMINISTRACION.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8819100A IT1215726B (it) | 1988-01-18 | 1988-01-18 | Formulazioni galeniche a cessione programmata. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2053702T3 true ES2053702T3 (es) | 1994-08-01 |
Family
ID=11154525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES88121777T Expired - Lifetime ES2053702T3 (es) | 1988-01-18 | 1988-12-28 | Nuevas formulas de galenica de accion programada. |
Country Status (16)
Country | Link |
---|---|
US (1) | US5043167A (es) |
EP (1) | EP0324981B1 (es) |
JP (1) | JPH01279823A (es) |
KR (1) | KR890011587A (es) |
AT (1) | ATE86480T1 (es) |
AU (1) | AU611517B2 (es) |
DE (1) | DE3879166T2 (es) |
DK (1) | DK18089A (es) |
ES (1) | ES2053702T3 (es) |
FI (1) | FI890238A (es) |
GR (1) | GR3007312T3 (es) |
IT (1) | IT1215726B (es) |
NO (1) | NO890194L (es) |
NZ (1) | NZ227631A (es) |
PT (1) | PT89467B (es) |
ZA (1) | ZA89100B (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5256699A (en) * | 1988-10-18 | 1993-10-26 | Ciba-Geify Corporation | Dispersible tablet formulation of diclofenac acid free base |
GB8824392D0 (en) * | 1988-10-18 | 1988-11-23 | Ciba Geigy Ag | Dispersible formulation |
US4948581A (en) * | 1989-02-17 | 1990-08-14 | Dojin Iyaku-Kako Co., Ltd. | Long acting diclofenac sodium preparation |
FR2649611A1 (fr) * | 1989-07-13 | 1991-01-18 | Philippe Perovitch | Procede de preparation galenique d'une composition therapeutique notamment a base d'aspirine |
US5368861A (en) * | 1989-10-26 | 1994-11-29 | Nippon Shinyaku Co., Ltd. | Gastric preparation with sustained release |
IE66933B1 (en) * | 1990-01-15 | 1996-02-07 | Elan Corp Plc | Controlled absorption naproxen formulation for once-daily administration |
JP2572673B2 (ja) * | 1990-07-25 | 1997-01-16 | エスエス製薬株式会社 | 徐放性錠剤 |
US5683721A (en) * | 1990-07-26 | 1997-11-04 | Perovitch; Philippe | Galenic preparation of therapeutic composition comprising aspirin |
JP2829794B2 (ja) * | 1991-02-08 | 1998-12-02 | エスエス製薬 株式会社 | 徐放性経口投与型プラノプロフェン製剤 |
DE4140184C2 (de) * | 1991-12-05 | 1995-12-21 | Alfatec Pharma Gmbh | Akutform für ein Flurbiprofen enthaltendes Arzneimittel |
WO1993017673A1 (en) * | 1992-03-03 | 1993-09-16 | Top Gold Pty., Limited | Sustained release analgesics |
FR2692146B1 (fr) * | 1992-06-16 | 1995-06-02 | Ethypharm Sa | Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention. |
US5609884A (en) * | 1992-08-31 | 1997-03-11 | G. D. Searle & Co. | Controlled release naproxen sodium plus naproxen combination tablet |
IT1258143B (it) * | 1992-09-11 | 1996-02-20 | Alfa Wassermann Spa | Compresse a cessione programmata contenenti naproxen |
IT1264020B (it) * | 1993-01-28 | 1996-09-09 | Recordati Chem Pharm | Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi |
GB9403857D0 (en) * | 1994-03-01 | 1994-04-20 | Scotia Holdings Plc | Fatty acid derivatives |
FR2735369B1 (fr) * | 1995-06-13 | 1997-07-11 | Synthelabo | Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside |
US5914134A (en) * | 1997-01-27 | 1999-06-22 | Wockhardt Europe Limited | Process for the pulsatile delivery of diltiazem HCL and product produced thereby |
US6312724B1 (en) | 1997-04-04 | 2001-11-06 | Isa Odidi | Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof |
EP1017370B1 (en) | 1997-09-11 | 2003-10-29 | Nycomed Danmark ApS | MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs) |
US6358060B2 (en) * | 1998-09-03 | 2002-03-19 | Jsr Llc | Two-stage transmucosal medicine delivery system for symptom relief |
SA99191255B1 (ar) | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
ES2337547T3 (es) * | 1999-09-28 | 2010-04-27 | Panacea Biotec Limited | Composiciones de liberacion controlada que contienen nimesulida. |
EP1239857B1 (en) * | 1999-12-22 | 2006-04-19 | Pharmacia Corporation | Dual-release compositions of a cyclooxygenase-2- inhibitor |
US6635277B2 (en) | 2000-04-12 | 2003-10-21 | Wockhardt Limited | Composition for pulsatile delivery of diltiazem and process of manufacture |
DE60118933T2 (de) | 2000-08-15 | 2006-11-30 | SurModics, Inc., Eden Prairie | Matrix zur aufnahme von arzneimitteln |
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
JP2005519053A (ja) * | 2002-01-09 | 2005-06-30 | ユ セ ベ ソシエテ アノニム | 放出が改良された薬剤 |
PT1591109E (pt) * | 2004-04-30 | 2008-09-05 | Desitin Arzneimittel Gmbh | Formulação exibindo libertação bifásica compreendendo um inibidor da desacetilase de histona |
US8642016B2 (en) | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
US8128460B2 (en) * | 2006-09-14 | 2012-03-06 | The Material Works, Ltd. | Method of producing rust inhibitive sheet metal through scale removal with a slurry blasting descaling cell |
US20110144207A1 (en) * | 2008-08-14 | 2011-06-16 | Shasun Chemicals And Drugs Limited | Aryl alkyl carboxylic acid salts, process for preparation and dosage forms |
CA2771831C (en) * | 2009-09-25 | 2018-03-06 | Novartis Ag | Oral pharmaceutical composition comprising diclofenac |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2793979A (en) * | 1953-03-30 | 1957-05-28 | Smith Kline French Lab | Method of making a sustained release pharmaceutical tablet and product of the method |
US4012498A (en) * | 1974-03-27 | 1977-03-15 | Sandoz, Inc. | Sustained release tablet formulations |
JPS5661311A (en) * | 1979-10-25 | 1981-05-26 | Fujisawa Pharmaceut Co Ltd | Thial amide or prolonged pharmaceutical preparation comprising its salt |
JPS5846019A (ja) * | 1981-09-14 | 1983-03-17 | Kanebo Ltd | 持続性ニフエジピン製剤 |
JPS6144811A (ja) * | 1984-08-10 | 1986-03-04 | Ss Pharmaceut Co Ltd | 徐放性ジクロフエナクナトリウム製剤 |
IT1200178B (it) * | 1986-07-23 | 1989-01-05 | Alfa Farmaceutici Spa | Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica |
JPS63162620A (ja) * | 1986-12-25 | 1988-07-06 | Teisan Seiyaku Kk | 遅溶性顆粒及びそれを用いた持続性複合顆粒 |
JPS63267720A (ja) * | 1987-04-24 | 1988-11-04 | Morishita Seiyaku Kk | エモルフアゾンの徐放性製剤 |
JPS6468317A (en) * | 1987-09-08 | 1989-03-14 | Dainippon Pharmaceutical Co | Durative preparation |
-
1988
- 1988-01-18 IT IT8819100A patent/IT1215726B/it active
- 1988-12-28 DE DE8888121777T patent/DE3879166T2/de not_active Expired - Fee Related
- 1988-12-28 AT AT88121777T patent/ATE86480T1/de active
- 1988-12-28 EP EP88121777A patent/EP0324981B1/en not_active Expired - Lifetime
- 1988-12-28 ES ES88121777T patent/ES2053702T3/es not_active Expired - Lifetime
-
1989
- 1989-01-03 AU AU27666/89A patent/AU611517B2/en not_active Ceased
- 1989-01-05 US US07/293,670 patent/US5043167A/en not_active Expired - Fee Related
- 1989-01-05 ZA ZA89100A patent/ZA89100B/xx unknown
- 1989-01-16 NZ NZ227631A patent/NZ227631A/en unknown
- 1989-01-17 NO NO89890194A patent/NO890194L/no unknown
- 1989-01-17 FI FI890238A patent/FI890238A/fi not_active IP Right Cessation
- 1989-01-17 PT PT89467A patent/PT89467B/pt not_active IP Right Cessation
- 1989-01-17 JP JP1009616A patent/JPH01279823A/ja active Pending
- 1989-01-17 DK DK018089A patent/DK18089A/da unknown
- 1989-01-17 KR KR1019890000426A patent/KR890011587A/ko not_active Application Discontinuation
-
1993
- 1993-03-11 GR GR930400082T patent/GR3007312T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0324981B1 (en) | 1993-03-10 |
NZ227631A (en) | 1990-12-21 |
DK18089D0 (da) | 1989-01-17 |
PT89467A (pt) | 1990-02-08 |
DE3879166T2 (de) | 1993-08-19 |
FI890238A0 (fi) | 1989-01-17 |
IT8819100A0 (it) | 1988-01-18 |
FI890238A (fi) | 1989-07-19 |
ZA89100B (en) | 1989-11-29 |
JPH01279823A (ja) | 1989-11-10 |
EP0324981A1 (en) | 1989-07-26 |
US5043167A (en) | 1991-08-27 |
ATE86480T1 (de) | 1993-03-15 |
NO890194L (no) | 1989-07-19 |
KR890011587A (ko) | 1989-08-21 |
GR3007312T3 (es) | 1993-07-30 |
DE3879166D1 (de) | 1993-04-15 |
AU2766689A (en) | 1989-07-20 |
NO890194D0 (no) | 1989-01-17 |
AU611517B2 (en) | 1991-06-13 |
IT1215726B (it) | 1990-02-22 |
DK18089A (da) | 1989-07-19 |
PT89467B (pt) | 1993-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2053702T3 (es) | Nuevas formulas de galenica de accion programada. | |
ES2002089T3 (es) | Nuevas formulaciones farmaceuticas con liberacion programada que contienen antiflogisticos. | |
ES2109899T1 (es) | Metodo, composiciones y kits para aumentar la biodisponibilidad oral de agentes farmaceuticos. | |
FI944035A (fi) | Tramadolisuolaa sisältävä lääkeaine, jolla on viivästynyt vaikuttavan aineen vapautuminen | |
ES2189803T3 (es) | Procedimiento. | |
UY27553A1 (es) | Formulaciones farmacéuticas de 5,7,14-triazatetraciclo(10.3.1.02,11.04,9)-hexadeca-2/11),3,5,7,9-pentaeno | |
CY1112260T1 (el) | Σκευασματα υδροκωδονης ελεγχομενης απελευθερωσης | |
DE1001772T1 (de) | Verbesserte verabreichungstechnik für multiple medikamentengaben | |
ATE198835T1 (de) | Knochenwachstumsfördernde zusammensetzung | |
AR240250A1 (es) | Procedimiento para la preparacion de una nueva formualcion farmaceutica oral que contiene omeprazol como ingrediente activo. | |
DE69628163D1 (de) | Nor-pregnane zur induzierung hypothalamischer effekte | |
ES2179832T3 (es) | Formas de administracion orales con contenido en flupirtina solida, con liberacion controlada del principio activo. | |
UY25950A1 (es) | Procedimiento para preparar composiciones de tratamiento oral para la prevencion de la resorcion osea | |
MC2025A1 (fr) | Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee | |
AR009113A1 (es) | UN PRODUCTO ANTICONCEPTIVO PARA DETENER LA OVULACIoN EN MUJERES DURANTE SU PERIODO DE ACTIVIDAD OVÁRICA | |
ES2118726T3 (es) | Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos. | |
MX9207171A (es) | Preparaciones farmaceuticas a liberacion programada. | |
TR199800765T2 (xx) | Otoim�n hastal�klar�n tedavisine mahsus bir farmas�tik bile�im | |
AR006202A1 (es) | Usos de antagonista ige para preparar un medicamento util para el tratamiento de las enfermedades alergicas y composiciones que los contiene | |
EA200200801A1 (ru) | Применение фолликулостимулирующего гормона (fsh) для лечения бесплодия | |
BR9912260A (pt) | Emplastro contendo um sistema terapêutico transdérmico e dose única para ministração | |
PE20011042A1 (es) | Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 324981 Country of ref document: ES |